Strategic Advisory Council

Shumeet Banerji, PhD

Mr. Banerji served as a senior partner of Booz & Company, (now Strategy&), from May 2012 until his retirement in March 2013. Previously, Mr. Banerji served as Chief Executive Officer of Booz & Company from July 2008 to May 2012. Prior to that, Mr. Banerji served in multiple roles at Booz Allen Hamilton, a consulting company and predecessor to Booz & Company, while based in offices in North America, Asia and Europe, including President of the Worldwide Commercial Business from February 2008 to July 2008, Managing Director, Europe from 2007 to February 2008 and Managing Director, United Kingdom from 2003 to 2007.

Mr. Banerji has advised public and private sector entities around the world, serving clients in the financial services, telecoms, technology and media, consumer products and retail, resources, steel, and chemicals industries. He has advised diversified conglomerates, investors, and governments. Typical issues have spanned the entire senior agenda, including corporate strategy, senior organization, board performance, transformational change, operational performance improvement, M&A, and compensation.
He is a frequent speaker at key economic and business conferences around the world including the World Economic Forum and the Global Economic Symposium. For the last few years he has focused on leadership issues in the aftermath of the financial crisis. He is the author of numerous articles and is co-author of Cut Costs and Grow Stronger.

Mr. Banerji serves on the Board of Directors of Hewlett-Packard Company, the Panel of Senior Advisers of Chatham House (The Royal Institute of International Affairs) and the Dean’s Advisory Board of the Kellogg School of Management, Northwestern University, where he received his Ph.D. He was a member of the faculty at the University of Chicago’s Graduate School of Business before joining the firm.

Timothy Cheney

Tim has devoted 35 years to understanding and advancing the treatment of brain disease through advocacy, education and research. His passion is deeply rooted; as a child, he suffered a debilitating TBI that had catastrophic impacts on his life and catalyzed the brain disease of addiction. Four years ago, Tim suffered a temporal lobe stroke and was diagnosed with Parkinson’s disease. Undaunted, and in recovery since 1981, he remains committed to finding solutions.

Currently Tim is the managing partner of Choopersguide.com, a technology advisor to C4 Recovery Solutions and a consultant to Patrick Kennedy’s addiction and mental health initiatives. Tim received a BA from Boston University (Summa Cum Laude with Distinction, Phi Beta Kappa) despite having attended only one semester of high school. He attended Yale Divinity School and holds designations of Certified Personnel Consultant and Certified International Personnel Consultant

After founding and selling two human resource and technology companies to an international public company, he served as SVP and Regional Executive SVP. As International Technology Division Chairman, he negotiated the Staffing industry’s first cooperation agreements with China in 2000.

Tim was the City of Boston Drug Treatment Program Research Director and the New Haven Community Correctional Center’s Program Director. As Boston’s SMSA representative and member of the Community Correspondents Group, he authored five NIDA epidemiological publications.

Tim has been active in the addiction treatment and child welfare communities for thirty one years. He serves on the following boards: Children’s Home Society of the Treasure Coast, Floridians for Recovery, Faces and Voices of Recovery and is a Member of Leadership Council for the Association of Recovery Organizations.

He is the recipient of the following advocacy awards: Children’s Home Society of Florida – Treasure Coast Division – The David & Lorraine Thomas Child Advocate Award (2009); Congressional Award – Flag of the United States for Advocacy with Foster Children (2009); Guardian AD Litem 19TH Judicial District – Florida Annual Child Advocacy Award (2006) and The Presidents Call to Service- Lifetime Achievement Award (2013).

Steve Hyman, MD

Steven E. Hyman, M.D. is director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard as well as Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. From 2001 to 2011, he served as provost of Harvard University, the University’s chief academic officer. In that role he helped shape the Broad Institute and Harvard’s Wyss Institute for Biologically Inspired Engineering. From 1996 to 2001, he served as director of the U.S. National Institute of Mental Health (NIMH), where he emphasized investment in neuroscience and emerging genetic technologies, as well as the establishment of DNA collections to facilitate genetic studies at large scale. He also initiated a series of large clinical trials with the goal of informing practice.

Hyman is president-elect of the Society for Neuroscience, editor of the Annual Review of Neuroscience, and was founding president of the International Neuroethics Society. He is a member of the Institute of Medicine of the U.S. National Academies where he serves on the Governing Council and Board of Health Science Policy, and chairs the Forum on Neuroscience and Nervous System Disorders, which brings together industry, government, academia, and voluntary organizations. He is a fellow of the American Academy of Arts and Sciences, a fellow of the American Association for the Advancement of Science, a fellow of the American College of Neuropsychopharmacology, and a Distinguished Life Fellow of the American Psychiatric Association.

Hyman received his B.A. summa cum laude from Yale College, a B.A. and M.A. from the University of Cambridge, which he attended as a Mellon fellow, and an M.D. cum laude from Harvard Medical School.

Zaven Khachaturian, PhD

Zaven Khachaturian, PhD, is the President of the Campaign to Prevent Alzheimer’s Disease by 2020 [PAS2020] Inc.(www.pad2020.org). He is also a senior science advisor to the Alzheimer’s Association; the Editor-in-Chief of Alzheimer’s & Dementia, the journal of the Alzheimer’s Association. He is generally acknowledged as the “Founder – Chief Architect” of the extramural research programs on the neurobiology of aging and Alzheimer’s supported by the National Institution on Aging (NIA) / National Institutes of Health [NIH]. Formerly he served as Director of the Office of Alzheimer’s Disease, responsible for coordinating all Alzheimer’s disease-related activities NIH-wide, as well as the Associate Director for the Neuroscience and Neuropsychology of Aging Program at the NIA/NIH. 

Curt Schreiner

Curt Schreiner is a 3-time Olympian and former member of the US Biathlon National Team. He was introduced to the sport of biathlon at age 12 when he watched the event at the 1980 Olympic Games in Lake Placid. With the help of the Saratoga Biathlon Club, his family went so far as to build a range at their home in the Adirondacks, and Curt had his own venue for training by the time he was 14. He soon became the strongest member of US Junior National Biathlon Team, and gained a berth on the Senior National Team in time to represent the US at the 1988 Olympics. His career as a world-class biathlete continued until 2002. He has won multiple national championships, competed in World Biathlon Championships and World Cup events all over the globe, and was a member of two additional US Olympic biathlon teams (1992 and 1994).

Curt joined the New York Army National Guard (NYARNG) in 1986. He was a member of the Army’s World Class Athlete program and National Guard Sports programs, which provided him the opportunity for full-time biathlon training. After his retirement from the sport, he was deployed for a 1-year tour of duty in 2005 as part of Operation Iraqi Freedom III. There, he commanded a Personnel Services Detachment in Tikrit, coming under mortar fire on a daily basis.

Curt was diagnosed with MS in 2007, while he was working full-time with the NYARNG. In May 2010, he retired from the NYARNG at the rank of Major. As a key member of the Orion Bionetworks team, he provides a unique perspective on the pursuit of better disease understanding and new treatments for MS.

Matthias Bowman

Mr. Bowman founded RCT Logic, LLC in 2008. Previously, he was Vice Chairman of Investment Banking at Merrill Lynch and Chief Executive Officer of Merrill Lynch Ventures.

Mr. Bowman is a founder of Fieldpoint Private Bank & Trust, and has previously served on the Board of Directors of MedAvante, Definity Health, Active Health Management, Borg-Warner Automotive, Del Monte Foods, Supermarkets General Corporation, Teleport Communications Group, and U.S. Foodservice.

Mr. Bowman manages the Bowman Family Foundation. He is also a member of the Board of Directors of the International Mental Health Research Organization (IMHRO) and the Sylvan C. Herman Foundation, and is a member of two Advisory Committees of Massachusetts General Hospital and the Board of Advisors of ACTTION (a public private partnership founded by the FDA which is focused on improving development of analgesic therapies). He was formerly a Trustee, member of the Executive Committee, and Chairman of the Finance Committee of the American Cancer Society Foundation, and a member of the Board of Directors and the Executive Committee of NARSAD.

Mr. Bowman attended Williams College, where he was elected Phi Beta Kappa in 1969 and graduated summa cum laude in 1970. In 1972 he graduated from the Harvard Business School as a Baker Scholar. In recent years he has studied Molecular Biology, Neuroscience and Biostatistics.

Rainer Fuchs, PhD

As Chief Information Officer for Harvard Medical School, Rainer Fuchs provides vision and leadership to the school’s IT department. Dr. Fuchs joined Harvard Medical School in 2012. Prior to that, he spent almost twenty years in the biopharmaceutical industry including twelve years with Biogen Idec, where he held the position of Vice President of R&D Information Technologies. He was also creator and executive director of the Biogen Idec Innovation Incubator (BI3) and instrumental in launching three startup drug discovery companies.

His experience in the biopharmaceutical sector includes senior leadership positions in life science informatics at Aventis, Ariad, and Glaxo Wellcome.  Prior to industry, Dr. Fuchs was a bioinformatics scientist at the European Molecular Biology Laboratory in Heidelberg. 

Dr. Fuchs was trained in Germany and holds a Ph.D. in Biochemistry from the University of Darmstadt and a Master degree in Microbiology from the University of Frankfurt.

Sean Hill, PhD

Sean Hill is  Scientific Director of the International Neuroinformatics Coordinating Facility (INCF) at the Karolinska Institutet in Stockholm, Sweden. Dr. Hill also serves as the co-Director of the Blue Brain Project and co-Director of Neuroinformatics in the European Union funded Human Brain Project (HBP) at the École Poly­tech­nique Fédérale de Lau­sanne (EPFL). 

Dr. Hill has extensive experience in building and simulating large-scale models of brain circuitry and currently supervises and leads research efforts exploring the principles underlying the structure and dynamics of neocortical and thalamocortical microcircuitry. He also serves in management and advisory roles on several large-scale clinical informatics initiatives around the world. 

After completing his Ph.D. in computational neuroscience at the Université de Lausanne, Switzerland, Dr. Hill held postdoctoral positions at The Neurosciences Institute in La Jolla, California and the University of Wisconsin, Madison, then joined the IBM T.J. Watson Research Center where he served as the Project Manager for Computational Neuroscience in the Blue Brain Project until his appointment at the EPFL. His research interests include the use of biologically-realistic models to study the role of emergent phenomena in information processing, network connectivity and synaptic plasticity in the central nervous system, from the neocortical column to the whole brain, and across different arousal conditions including waking and sleep.

Thomas Miller

After earning an SM from the Harvard/MIT Health Sciences and Technology program, Tom joined Siemens where he ran the global MRI business. He has also served as the CEO of the global medical operations of Carl Zeiss, the CEO of Analogic Corporation, and Chairman and CEO of LightLab Imaging, a start-up he helped to establish and sell. Tom rejoined Siemens in 2002, eventually serving as a member of the global operating board of Siemens Healthcare and the CEO of Customer Solutions Division, with 26,000 employees in over 130 countries. In April 2013, Tom started GreyBird Ventures, a consultancy and investment firm.

Kristen Rosati, JD

Kristen Rosati has deep experience in HIPAA compliance and data breaches, electronic health record roll-outs, health information exchange, data sharing for research and clinical integration initiatives, clinical research compliance, clinical trials contracting, biobanking, and all things “Big Data.”

Kristen Rosati is the Immediate Past President of the American Health Lawyers Association (AHLA), the nation’s largest educational organization devoted to legal issues in the healthcare field with almost 13,000 members. She has served as a member of its Board of Directors since 2006.   Kristen has been listed in Best Lawyers in America for health care since 2007 and is Best Lawyers’ 2014 Phoenix Health Care Law “Lawyer of the Year.” She was chosen as one of the 50 Most Influential Women in Arizona Business in 2013 by Arizona Business Magazine, and was awarded the Health Care Leadership Award for Legal Advocate of the Year in 2014.

Kristen is an advisor to the FDA Sentinel Initiative, an effort to create a national electronic distributed network to monitor medical product safety. She is serving on the Privacy Panel for the “Mini-Sentinel Coordinating Center” at Harvard Pilgrim, and on the Brookings Active Surveillance Implementation Council. She is a member of eHealth Initiative’s National Council on Data and Analytics, and is on the Strategic Advisory Council for Orion Bionetworks.

Kristen is working with the Arizona Biomedical Research Commission to build clinical and translational research capacity in Arizona, including developing a “virtual” tissue bank, creating educational resources and assisting in the creation of collaborative IRB resources. She served on the planning committee for the 2014 Annual Meeting of the International Society of Biomedical and Environmental Biorepositories.

Kristen chairs the Legal Committee for Arizona Health-e Connection and the Health Information Network of Arizona, Arizona’s e-health initiatives, and was a member of the National Governor’s Association State Alliance for e-Health, Health Information Protection Task Force. She chaired the legal work for the Adoption of Standard Policies Collaborative, part of the Health Information Privacy and Security Collaboration (HISPC) funded by the Office of the National Coordinator for Health Information Technology.

Kristen was a member of the Advisory Board for the Arizona State University (ASU) Biomedical Informatics Department and a founding Executive Committee member of the ASU Center for Health Care Innovation and Clinical Trials. She has been an adjunct professor of law and frequent guest lecturer at ASU. Ms. Rosati lectures nationally on data sharing for research, data breaches and HIPAA compliance, and has written numerous articles and book chapters on these issues.

Kristen received her B.A., with high honors, and her J.D., cum laude, from the University of Michigan.   She clerked for the late Judge Thomas Tang of the U.S. Court of Appeals for the Ninth Circuit and for Judge Earl H. Carroll of the U.S. District Court for the District of Arizona.

Stephen Kennedy Smith

Mr. Stephen E. Kennedy-Smith, Jr. is a Founding Partner of KSS Realty Partners. Mr. Kennedy-Smith serves as a Member of the Technology Advisory Board of Gridline Communications Holdings, Inc. and as Member of Strategic Advisory Board of RAPID Pharmaceuticals AG. Mr. Kennedy-Smith has been Chairman of the Advisory Committee at Mainland Resources Inc. since March 2010. 

Mr. Kennedy-Smith has been a Director of Med-Design Corp. since September 23, 2003. He is an active member of the Kennedy family financial advisory board. He founded and chairs the Social Media company and Kennedy Smith Sammaweera, a real estate investment and development business. He has delivered keynote presentations at the annual conferences of the Family Firm Institute and the Family Office Exchange – two major family business organizations. 

He served as Deputy Campaign Manager for Senator Edward Kennedy during his presidential and senatorial campaigns. He also served on the staff of the Senate Judiciary and Foreign Relations Committees, and taught negotiation at Harvard University Law School. He is a three-time winner of Harvard’s Danforth Award for Excellence in Teaching and a recipient of the Lyndehurst Foundation prize for social and artistic achievement. Mr. Kennedy-Smith holds an M.A. from Harvard University, a J.D. from Columbia University, and an M.A. Ed. from Harvard’s School for Education.

Nick Zakrasek

Nick Zakrasek is an experienced leader in the business applications of big data and computational modeling.  He is currently Product Manager for Google’s Knowledge Engine, and was the founding program manager for the launch of Orion Bionetworks in 2012.

Prior to Orion, Nick spent six years working in international aerospace operations for Rockwell Collins.. He holds an MBA from Stanford’s Graduate School of Business, and a BA in mathematics and East Asian studies from Brown University.